Non-viral Opportunistic Infections in New Users of TNF Inhibitor Therapy: Results of the SAfety Assessment of Biologic ThERapy (SABER) Study

OBJECTIVES: To determine among patients with autoimmune diseases in the United States whether the risk of non-viral opportunistic infections (OIs) was increased among new users of tumor necrosis factor-alpha inhibitors (TNFI), when compared to users of non-biologic agents used for active disease. ME...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ann Rheum Dis
Main Authors: Baddley, John W., Winthrop, Kevin L., Chen, Lang, Liu, Liyan, Grijalva, Carlos G, Delzell, Elizabeth, Beukelman, Timothy, Patkar, Nivedita M., Xie, Fenglong, Saag, Kenneth G., Herrinton, Lisa J., Solomon, Daniel H., Lewis, James D., Curtis, Jeffrey R.
Formato: Artigo
Idioma:Inglês
Publicado: 2013
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4273901/
https://ncbi.nlm.nih.gov/pubmed/23852763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2013-203407
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares